Kai Shen

发表

Pharmacokinetics, pharmacodynamics, and safety of esomeprazole injection/infusion in healthy Chinese volunteers: A five‐way crossover study

J. Qian, Jingnan Li, Ji Jiang, 2013, Journal of gastroenterology and hepatology.

Study on Pharmacokinetic Interactions Between HS-10234 and Emtricitabine in Healthy Subjects: An Open-Label, Two-Sequence, Self-Controlled Phase I Trial

Guoping Yang, Jie Huang, Shuang Yang, 2021, Infectious Diseases and Therapy.

A novel 4.9 Kb deletion at beta-globin gene is identified by the third-generation sequencing: case report from Baoan, China.

Jiaqi Li, Guang-xing Mai, Zehao Yan, 2022, Clinica chimica acta; international journal of clinical chemistry.

Safety, pharmacokinetics, and pharmacodynamics of SHR7280, an oral gonadotropin-releasing hormone antagonist in healthy premenopausal women

Yixiang Xu, Ping Shi, Yu Cao, 2022, Frontiers in Pharmacology.

Disease Burden of Total and Early-Onset Colorectal Cancer in China from 1990 to 2019 and Predictions of Cancer Incidence and Mortality

Jun Li, Weiling Hu, Yanyong Deng, 2023, Clinical epidemiology.

Pharmacokinetic and Pharmacodynamic Modeling Analysis of Intravenous Esomeprazole in Healthy Volunteers

Dongyang Liu, Ji Jiang, P. Hu, 2016, Journal of clinical pharmacology.

Pharmacokinetics and Safety of Tedizolid after Single and Multiple Intravenous/Oral Sequential Administrations in Healthy Chinese Subjects.

P. Hu, Kai Shen, Toshiaki Tanaka, 2016, Clinical therapeutics.

Cytochrome P450 2D6 genotype affects the pharmacokinetics of controlled-release paroxetine in healthy Chinese subjects: comparison of traditional phenotype and activity score systems

P. Hu, Jun Shi, Kai Shen, 2015, European Journal of Clinical Pharmacology.

Pharmacokinetics and Tolerability of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate and Glycopyrronium/Formoterol Fumarate Dihydrate Metered Dose Inhalers in Healthy Chinese Adults: A Randomized, Double-blind, Parallel-group Study.

P. Dorinsky, P. Assam, Qian Chen, 2019, Clinical therapeutics.

Safety, pharmacokinetics, and pharmacodynamics of SHR7280, an oral gonadotropin-releasing hormone receptor antagonist, in healthy men: a randomized, double-blind, placebo-controlled phase 1 study

Fei-fei Sun, Yu Cao, Kai Shen, 2023, BMC Medicine.

Multiple doses of SHR-1222, a sclerostin monoclonal antibody, in postmenopausal women with osteoporosis: A randomized, double-blind, placebo-controlled, dose-escalation phase 1 trial

X. Yan, Bo Wu, J. Shentu, 2023, Frontiers in Endocrinology.

Mass balance study of [14C]SHR0302, a selective and potent JAK1 inhibitor in humans

Yan Zhan, Hua Zhang, Sheng Ma, 2023, Xenobiotica; the fate of foreign compounds in biological systems.

Effect of CYP3A4 induction and inhibition on the pharmacokinetics of SHR0302 in healthy subjects

Ping Zhang, Xin Li, Yuan Li, 2023, British journal of clinical pharmacology.

Cytochrome P450 2D6 genotype affects the pharmacokinetics of controlled-release paroxetine in healthy Chinese subjects: comparison of traditional phenotype and activity score systems

P. Hu, Jun Shi, Kai Shen, 2015, European Journal of Clinical Pharmacology.